Zevra Therapeutics, Inc. Line of Credit Facility, Maximum Amount Outstanding During Period
Zevra Therapeutics, Inc. (ZVRA) reported Line of Credit Facility, Maximum Amount Outstanding During Period of $12.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod · last filed 2024-04-01
- Zevra Therapeutics, Inc. line of credit facility, maximum amount outstanding during period for the quarter ending 2022-12-31 was $0.00.
- Zevra Therapeutics, Inc. line of credit facility, maximum amount outstanding during period for the quarter ending 2022-09-30 was $0.00.
- Zevra Therapeutics, Inc. line of credit facility, maximum amount outstanding during period for fiscal 2022 was $12.80M.
| Period end | Line of Credit Facility, Maximum Amount Outstanding During Period 3 month | Line of Credit Facility, Maximum Amount Outstanding During Period 6 month | Line of Credit Facility, Maximum Amount Outstanding During Period 9 month | Line of Credit Facility, Maximum Amount Outstanding During Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $12.80M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $12.80M 10-Q · filed 2023-08-14 | ||
| 2022-06-30 | $12.80M 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |